“Global Longitudinal Strain of Chronic Granulocytic Leukemia Patients treated with Imatinib and Nilotinib” (2021) International Journal of Integrated Health Sciences, 9(2), pp. 49–54. doi:10.15850/ijihs.v9n2.2217.